HERC2 pseudogene 10 (HERC2P10)

HERC2 pseudogene 10 (HERC2P10) is a processed pseudogene derived from the parental gene HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2)[2][4]. Pseudogenes like HERC2P10 do not encode functional proteins, and to date, there are no known direct biological functions, disease roles, drug interactions, or biomarker utility for HERC2P10 itself[2][4]. Information about other HERC2 pseudogenes such as HERC2P2 indicates possible regulatory roles at the RNA level through mechanisms like ceRNA in cancer, but no such function or clinical relevance is yet established for HERC2P10 specifically. Most references to HERC2P10 simply list it as a genomic pseudogene with no evidence that it is a therapeutic target, receptor, enzyme, or that it has any established function or clinical association[2][4]. Summary assessment: - HERC2 pseudogene 10 is not considered a therapeutic target. - There is nothing to suggest it is a receptor, enzyme, transporter, or similar target. - Its designation as a pseudogene means it is an inactive genomic remnant and not a functional molecule. - No roles in disease, biomarkers, or mechanisms of action are known for this specific pseudogene according to current data[2][4]. If a specific functional role for HERC2P10 is discovered in the future, these fields should be updated; current literature supports its classification as a nonfunctional pseudogene.

Other names

HERC2P10HERC2 pseudogene 10